Evidence map›Paper›PMID 39188037›Full record

ReviewMedical science monitor : international medical journal of experimental and clinical research2024

Navigating Anesthesia: Muscle Relaxants and Reversal Agents in Patients with Renal Impairment.

Paweł Radkowski, Karol Jan Krupiniewicz, Mariusz Suchcicki, Natalia Joanna Machoń, Sara Cappello, Maciej Szewczyk, Joanna Maria Wolska, Tomasz Stompór

Abstract readReview
In one paragraph

Review in Medical science monitor : international medical journal of experimental and clinical research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Muscle-Specific Differences in Neuromuscular Block and Quantitative Neuromuscular Monitoring: A Narrative Review.Medical science monitor : international medical journal of experimental and clinical research · 2026
    Review
  2. Narrative Review of the Role of Nondepolarizing Neuromuscular Blocking Agents in Anesthesia: Perspective 2026.Medical science monitor : international medical journal of experimental and clinical research · 2026
    Review
  3. Review
  4. Article
  5. Comprehensive Review of Anesthetic Strategies for Patients With Neurodegenerative Diseases.Medical science monitor : international medical journal of experimental and clinical research · 2026
    Review
  6. Review
  7. Age-Specific Pharmacology of Neuromuscular Blocking Agents: A Comprehensive Review.Medical science monitor : international medical journal of experimental and clinical research · 2025
    Review
  8. Use of Muscle Relaxants in Emergency Medicine: A Review.Medical science monitor : international medical journal of experimental and clinical research · 2025
    Review
  9. Article
  10. Advances in Neuromuscular Monitoring Techniques in Anesthesiology: A 2025 Perspective.Medical science monitor : international medical journal of experimental and clinical research · 2025
    Review
  11. Skeletal Muscle Relaxants and Their Impact on Intracranial Pressure in Neurosurgery.Medical science monitor : international medical journal of experimental and clinical research · 2025
    Review
  12. Review
  13. Review
  14. Impact of Liver Disease on Use of Muscle Relaxants in Anesthesia: A Comprehensive Review.Medical science monitor : international medical journal of experimental and clinical research · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Paweł RadkowskiDepartment of Anesthesiology and Intensive Care, Faculty of Medicine, Collegium Medicum University of Warmia and Mazury, Olsztyn, Poland.ORCID 0000-0002-9437-9458
Karol Jan KrupiniewiczFaculty of Medicine, Collegium Medicum University of Warmia and Mazury, Olsztyn, Poland.ORCID 0009-0004-4255-4412
Mariusz SuchcickiFaculty of Medicine, Collegium Medicum University of Warmia and Mazury, Olsztyn, Poland.ORCID 0009-0008-6988-4664
Natalia Joanna MachońFaculty of Medicine, Collegium Medicum University of Warmia and Mazury, Olsztyn, Poland.ORCID 0000-0003-2104-4646
Sara CappelloFaculty of Medicine and Surgery, University of Cagliari, Cagliari, Italy.ORCID 0009-0006-5148-2128
Maciej SzewczykResidency in Rheumatology, University Clinical Hospital No. 1 in Szczecin, Szczecin, Poland.ORCID 0009-0009-0818-4848
Joanna Maria WolskaDepartment of Anaesthesiology and Intensive Care, Regional Specialist Hospital, Olsztyn, Poland.ORCID 0000-0002-5748-5665
Tomasz StompórDepartment of Nephrology, Transplantology and Internal Diseases, Collegium Medicum University of Warmia and Mazury, Olsztyn, Poland.ORCID 0000-0002-3944-0850

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This comprehensive review explores the interaction between neuromuscular blocking agents, reversal agents, and renal function, focusing on various drugs commonly used in anesthesia and their effects on kidney health. Succinylcholine, commonly used for anesthesia induction, can trigger elevated potassium levels in patients with specific medical conditions, leading to serious cardiac complications. While studies suggest the use of succinylcholine in patients with renal failure is safe, cases of postoperative hyperkalemia warrant further investigation. Some agents, such as atracurium and mivacurium, are minimally affected by impaired kidney function, whereas others, such as cisatracurium and rocuronium, can have altered clearance, necessitating dose adjustments in patients with renal failure. The reversal agents neostigmine and sugammadex affect renal markers, while cystatin C levels remain relatively stable with sugammadex use, indicating its milder impact on glomerular function, compared with neostigmine. Notably, the combination of rocuronium and sugammadex in rat studies shows potential nephrotoxic effects, cautioning against the simultaneous use of these agents. In conclusion, understanding the interplay between neuromuscular blocking agents and renal function is crucial for optimizing patient care during anesthesia. While some agents can be used safely in patients with renal failure, others can require careful dosing and monitoring. Further research is needed to comprehensively assess the long-term impact of these agents on kidney health, especially in high-risk patient populations. This article aims to review the use of muscle relaxants and reversal for anesthesia in patients with impaired renal function.

Indexed as

AnesthesiaNeuromuscular AgentsPostoperative ComplicationsRenal InsufficiencyAnimalsDose-Response Relationship, DrugGlomerular Filtration RateKidneyNeostigmineRocuroniumSuccinylcholineSugammadexNeostigmineNeuromuscular AgentsRocuroniumSuccinylcholineSugammadex

Identifiers

PMID39188037
PMCPMC11365435

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.